Sustainability. We mean it.

Sustainable Global Equity, 2023

10 April 2024 |
While treatments for obesity have dominated the healthcare investment narrative over the past 18 months, they are by no means the only secular growth story. In this report, the Sustainable Global Equity team explain why the life sciences industry is well positioned to benefit from structural trends.
Sustainable Global Equity, 2023

Fast reading:

  • Investment review, 2023
  • Engagement overview: 59 engagement objectives with 42 companies engaged
  • Thematic focus: How life sciences are enabling today’s healthcare treatment – and tomorrow’s healthcare innovation
  • Engagement case study: Lonza Group
  • Engagement case study: Thermo Fisher

Sustainable Global Equity, 2023


Please view previous reports below:

Watch this video to hear Martin Todd, Portfolio Manager, respond to the key questions surrounding sustainable investing.

Please visit the strategy’s capability page to learn more.

Sustainable Global Equity, 2023

Related insights

Lightbulb icon

Get the latest insights straight to your inbox